CINECA IRIS Institutional Research Information System

MEDICO, Enzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.375
EU - Europa 7.635
AS - Asia 7.194
SA - Sud America 724
OC - Oceania 100
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 21
Totale 30.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.120
CN - Cina 3.215
IT - Italia 2.457
SG - Singapore 2.023
DE - Germania 999
BR - Brasile 617
IE - Irlanda 585
GB - Regno Unito 494
SE - Svezia 490
FI - Finlandia 460
FR - Francia 439
JP - Giappone 382
AT - Austria 368
KR - Corea 314
UA - Ucraina 262
IN - India 248
VN - Vietnam 239
HK - Hong Kong 219
PL - Polonia 204
CA - Canada 175
NL - Olanda 171
ES - Italia 121
BE - Belgio 120
ID - Indonesia 109
TW - Taiwan 106
AU - Australia 88
DK - Danimarca 86
CH - Svizzera 69
RU - Federazione Russa 67
TR - Turchia 65
MX - Messico 64
AR - Argentina 44
IR - Iran 41
RO - Romania 40
TH - Thailandia 40
CZ - Repubblica Ceca 29
GR - Grecia 27
PT - Portogallo 27
SN - Senegal 27
NO - Norvegia 26
IL - Israele 25
BD - Bangladesh 23
UZ - Uzbekistan 22
ZA - Sudafrica 22
MY - Malesia 21
PK - Pakistan 19
EU - Europa 17
IQ - Iraq 15
HU - Ungheria 13
CL - Cile 12
NZ - Nuova Zelanda 12
CO - Colombia 11
EC - Ecuador 11
LT - Lituania 11
RS - Serbia 10
PH - Filippine 9
VE - Venezuela 9
SA - Arabia Saudita 8
AL - Albania 7
BA - Bosnia-Erzegovina 7
BG - Bulgaria 7
EG - Egitto 7
PY - Paraguay 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
KE - Kenya 6
KZ - Kazakistan 6
MA - Marocco 6
BY - Bielorussia 5
HR - Croazia 5
JO - Giordania 5
LB - Libano 5
LU - Lussemburgo 5
PE - Perù 5
SI - Slovenia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BN - Brunei Darussalam 4
LK - Sri Lanka 4
MO - Macao, regione amministrativa speciale della Cina 4
NG - Nigeria 4
A1 - Anonimo 3
AZ - Azerbaigian 3
BO - Bolivia 3
EE - Estonia 3
GE - Georgia 3
MD - Moldavia 3
AM - Armenia 2
BB - Barbados 2
DM - Dominica 2
GD - Grenada 2
JM - Giamaica 2
MK - Macedonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CI - Costa d'Avorio 1
Totale 30.114
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.514
Chandler 1.106
Singapore 1.055
Beijing 1.006
Ashburn 953
Fairfield 907
Houston 732
Dublin 560
Santa Clara 530
Torino 475
Woodbridge 423
Seattle 387
Cambridge 341
Wilmington 338
Shanghai 313
Vienna 301
Turin 256
Dearborn 253
Redwood City 217
Dallas 209
Nyköping 204
Pisa 204
Guangzhou 180
Villeurbanne 180
Jacksonville 171
Medford 167
Warsaw 161
Milan 157
Princeton 153
Munich 149
Columbus 147
Los Angeles 147
New York 142
Tokyo 138
Hong Kong 127
Hangzhou 122
Lappeenranta 112
Nanjing 109
Buffalo 105
Boardman 100
Jakarta 92
Dong Ket 89
Seoul 86
Helsinki 84
The Dalles 81
Wuhan 81
Fremont 79
Hefei 78
Boston 76
Brussels 70
Taipei 67
San Diego 66
Rome 65
Phoenix 59
São Paulo 58
Turku 56
Amsterdam 55
Genoa 54
Nuremberg 54
Changsha 53
Naples 52
Shenyang 50
Toronto 50
Chengdu 48
London 46
Bengaluru 45
Eitensheim 40
Paris 40
Frankfurt am Main 38
Ottawa 38
Zhengzhou 37
Norwalk 35
Silver Spring 35
Nanchang 32
Washington 31
Chongqing 30
Jinan 29
Redondo Beach 29
Verona 29
Xian 29
Bangkok 28
Chicago 28
Düsseldorf 28
Falls Church 28
Kunming 28
Berlin 27
Fuzhou 27
Ho Chi Minh City 27
Melbourne 27
San Francisco 26
Moscow 25
Barcelona 24
Bologna 24
Belfast 23
Hanoi 22
Southend 22
Tianjin 22
Florence 21
Mountain View 21
Rio de Janeiro 20
Totale 18.515
Salva come PNG Salva come JPEG
Nome #
Stromal contribution to the colorectal cancer transcriptome. 2.035
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 852
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 847
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 841
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 760
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 663
Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer 636
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. 577
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 558
MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. 439
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 429
Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer 383
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 380
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 378
MicroRNA–mRNA interactions underlying colorectal cancer molecular subtypes 350
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 330
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 307
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 306
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 305
Only a subset of Met-activated pathways are required to sustain oncogene addiction 290
Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy 284
The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer. 281
Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18 F-FDG PET and MRI radiomics features 280
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin 274
Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. 273
Analisi del profilo di trascrizione genetica nella sindrome di Noonan. 270
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 268
Met-driven invasive growth involves transcriptional regulation of Arhgap12 262
Inhibition of Src impairs the growth of met-addicted gastric tumors. 262
Transcriptional hallmarks of noonan syndrome and noonan-like syndrome with loose anagen hair 261
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 260
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 259
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 257
Evolving neoantigen profiles in colorectal cancers with DNA repair defects 256
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 252
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 242
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 238
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 237
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 235
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 232
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 228
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 220
Exploiting orthologue diversity for systematic detection of gain-of-functionphenotypes 218
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart 213
Detection of gene communities in multi-networks reveals cancer drivers 213
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. 212
Sustained Met signalling in the heart leads to cardiac compensated hypertrophy and remodelling, which evolves into congestive heart failure 209
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas 209
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature 199
Mulcom: a multiple comparison statistical test for microarray data in Bioconductor 199
Electrical conditioning of adipose-derived stem cells in a multi-chamber culture platform 196
A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells 195
Patient-derived xenografts (PDXs) as model systems for human cancer 194
Isolation and Characterization of a Spontaneously Immortalized Multipotent Mesenchymal Cell Line Derived from Mouse Subcutaneous Adipose Tissue 192
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. 184
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 182
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 180
Semalytics: a semantic analytics platform for the exploration of distributed and heterogeneous cancer data in translational research 178
Generation of Functional Hepatocytes from Mouse Germline Cell-derived Pluripotent Stem Cells in vitro 176
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers 175
PDX-MI: Minimal information for patient-derived tumor xenograft models 172
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 170
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 170
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies 165
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 165
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. 162
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds 162
Transcriptional signature of Pseudomyxoma Peritonei: An enhancement of treatment strategy and outcome prediction 159
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. 158
A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. 158
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 157
Mek inhibition in a newborn with raf1-associated noonan syndrome ameliorates hypertrophic cardiomyopathy but is insufficient to revert pulmonary vascular disease 156
Formalin fixation at low temperature better preserves nucleic acid integrity. 153
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 152
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 151
Anaplastic large-cell lymphoma 150
Gene expression profiling of HGF/Met activation in neonatal mouse heart 149
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 147
Genome-wide analysis of unliganded estrogen receptor binding sites in breast cancer cells 147
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 145
A gene trap vector system for identifying transcriptionally responsive genes 140
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer 140
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 139
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib 136
Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3. 135
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine 134
Reverse signaling by semaphorin 4C elicits SMAD1/5- And ID1/3-dependent invasive reprogramming in cancer cells 130
Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells 128
Biochemical and immunological properties of the human carcinoma antigen CAR-5 defined by the monoclonal antibody BD-5. 127
Cancer and blood coagulation 126
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power 124
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 120
Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. 118
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 115
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle. 114
The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. 113
Ionizing radiation fosters cancer invasion through transcriptional up-regulation of the MET oncogene 113
Molecular anatomy of peripheral T cell lymphomas 111
New mouse models to study HGF/Met role in postnatal heart development and heart disease pathogenesis 110
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle. 109
Totale 26.451
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.869
article - articoli 0
book - libri 0
conference - conferenze 9.467
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.336
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.217 0 0 0 0 223 249 301 170 265 292 196 521
2021/20224.747 480 426 408 493 359 332 418 343 220 218 615 435
2022/20233.553 365 295 102 329 324 735 222 259 451 96 217 158
2023/20242.404 247 278 142 162 163 303 157 226 56 213 239 218
2024/20254.689 135 217 278 387 928 375 207 290 494 393 375 610
2025/20262.904 872 371 576 910 175 0 0 0 0 0 0 0
Totale 30.704